Bharat Biotech International Limited is a biotechnology company based in Hyderabad, India. The company was founded in 1996 and is focused on developing vaccines, biotherapeutics, and pharmaceuticals. Bharat Biotech is one of the leading vaccine manufacturers in India and has developed a number of vaccines for diseases such as rotavirus, Japanese encephalitis, and typhoid fever.
In 2020, Bharat Biotech developed Covaxin, an indigenously developed COVID-19 vaccine in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). Covaxin is an inactivated virus vaccine and was granted emergency use authorization in India in January 2021.
Bharat Biotech has also established collaborations with various organizations and companies in India and around the world to develop and manufacture vaccines and other biopharmaceutical products. The company has received several awards and recognition for its contributions to the field of biotechnology and healthcare.
Bharat Biotech International is a Hyderabad based multidimensional biotechnology company offers affordable, safe and effective healthcare solutions.
Products : IMMUTIKA Vaccines - Revac-B+, TYPBAR, BIOGIT, BIOPOLIO, INDIRAB, Revac-Bmcf, TEVAC, ZELECT, RENOVA Bio-therapeutics Division - REGEN-D 150, BIO-ENOX, BIO-OSTEON etc
BBIL website has details about products, services - co-marketing in domestic and international market, contract manufacturing, milestones, media center, careers etc
Genome Valley Shameerpet
Hyderabad - 500 078 AP INDIA
Ph: +91 40 2348 0567
Fax: +91 40 2348 0560
Email: info@bharatbiotech.com
Web : http://www.bharatbiotech.com/